Goldline Pharmaceutical Ltd.

BSE: 544759

Goldline Pharmaceutical Live Share Price Today, Share Analysis and Chart

Name: Goldline Pharmaceutical Ltd.: Is Infosys Ltd. worth buying?
Item: Goldline Pharmaceutical Ltd.
Rating: 1.48225
Author: Trendlyne DVM scores

aboutGoldline Pharmaceutical was incorporated on August 02, 2004. The company markets pharmaceutical products under the “Goldline” brand across five segments, including pharma, wellness, and ayurvedic categories. Its products are manufactured through thir... Read More

0.00(0.00%)

6,000

BSE Volume

BSE 30 Oct, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

- / 100

22.8 / 100

No estimates available

SWOT Analysis

Check Before You Buy

VIEW FULL CHECKLIST

Medium rank

6Positive7Negative

46.2%Pass in checklist

045

100

Check P/E Buy Sell Zone

Sell Zone

67.0 % into P/E buy sell zone

% time spent below current P/E

020406080100

Strong upside potential

Gains already realized

Goldline Pharmaceutical Stock Price Analysis

Week Price Range 3.6% 1 Week return	31.2 (LTP) 30.533 LowHigh
Month Price Range -1.6% 1 Month return	31.2 (LTP) 28.134.8 LowHigh

View full Price History/Seasonality

Competitors/Peers

Annual

Balance Sheet

Ratios

Cash Flow

Documents

Goldline Pharmaceutical annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Annual Revenue Goldline Pharmaceutical Mar-2026 Annual Revenue is Rs 31 Cr which is growth of 11.2% YoY.
POSITIVE
Annual Net Profit Goldline Pharmaceutical Mar-2026 Annual Net Profit is Rs 4 Cr which is growth of 45.4% YoY.

Goldline Pharmaceutical Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21
SR_A Total Rev. Ann. ⌄	16.2%	7.3%	31.2	28.1	23.6	19.9	24	21.9
TotalOperatingRevenues_A Operating Rev. Ann.	16.2%	7.3%	31.2	28.1	23.6	19.9	24	21.9
OI_A Other Income Ann.	-	-					0	0
OEXPNS_A Operating Exp. Ann.	11.1%	3.6%	24.3	22.2	19.3	17.7	22.3	20.4
OEXPNS_A Operating Exp. Ann.	11.1%	3.6%	24.3	22.2	19.3	17.7	22.3	20.4
OP_A Operating Profit Ann.	46.4%	35.7%	6.9	5.8	4.3	2.2	1.7	1.5
OPMPCT_A OPM Ann. %	26.2%	26.3%	22.24%	20.78%	18.25%	11.06%	7.02%	6.93%
TotalExpenses_A Total Exp. Ann. ⌄	9.8%	3.6%	25.8	24.2	21	19.5	23.6	21.6
OtherExpenses_A Other Exp. Ann.	-2.1%	35.8%	6	5.7	7.6	6.4	1.6	1.3
EmployeeBenefitExpenses_A Employee Exp. Ann.	9.6%	7.7%	7.1	5.8	5.6	5.4	5.4	4.9
CostOfPowerPurchased_A Cost Of Power Purchased Ann.	-	-
CostOfFuel_A Cost Of Fuel Ann.	-	-
EBIDT_A EBITDA Ann.	46.4%	35.7%	6.9	5.8	4.3	2.2	1.7	1.5
EBIDTPCT_A EBITDA Ann. margin %	26.2%	26.2%	22.25%	20.78%	18.25%	11.06%	7.05%	6.96%
INT_A Interest Ann.	-6.7%	1.6%	1.3	1.7	1.6	1.6	1.2	1.2
DEP_A Depr.	0%	14.9%	0.2	0.3	0.2	0.2	0.1	0.1
PBT_A PBT Ann.	138.1%	78.3%	5.4	3.9	2.5	0.4	0.5	0.3
TAX_A Tax Ann.	135.1%	67%	1.3	1	0.7	0.1	0.1	0.1
PAT_A PAT Before ExtraOrdinary Items Ann. ⌄	139.1%	83%	4.1	2.8	1.8	0.3	0.3	0.2
IncomeMinorityInterest_A Minority Interest Income Ann.	-	-	-	-	-	-	-	-
NP_A Net Profit Ann.	139.1%	83%	4.1	2.8	1.8	0.3	0.3	0.2
NETPCT_A NPM Ann. %	117%	69.6%	13.19%	10.09%	7.65%	1.29%	1.38%	0.94%
EPS_adj_A EPS Adj. latest Ann.	142.9%	84.7%	4.3	3	1.9	0.3	0.4	0.2

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

VIEW ALL TABLE IN FINANCIAL PAGE

Total Rev. Ann.

1Y CHG

11%

2Y CAGR

15%

3Y CAGR

16.2%

5Y CAGR

7.3%

Total Revenue Annual growth is stable compared to historical averages.

Net Profit Ann.

1Y CHG

46.4%

2Y CAGR

50.9%

3Y CAGR

139.1%

5Y CAGR

83%

Net Profit Annual growth is lower than historical averages.

Operating Exp. Ann.

1Y CHG

9.5%

2Y CAGR

12.2%

3Y CAGR

11.1%

5Y CAGR

3.6%

Operating Expenses Annual Cr growth is stable compared to historical averages.

Goldline Pharmaceutical Technical Analysis

Goldline Pharmaceutical EMA & SMA

Bearish-7

0 bullish, 7 bearish

Bullish0

Bearish7

5 Day	31.3
10 Day	31.5
12 Day	31.6
20 Day	32.2

26 Day	32.8
50 Day	35.0
100 Day	39.4

Goldline Pharmaceutical Delivery And Volume

Daily Avg. Delivery Volume %

30 Oct, 2026100.0%

Week90.9%

Month84.7%

Goldline Pharmaceutical Active Candlesticks

Short Line Uptrend

Legend

Positive IndicatorNeutral IndicatorNegative Indicator

Goldline Pharmaceutical Resistance and Support

31.20

Pivot

First Resistance	31.2
Second Resistance	31.2
Third Resistance	31.2

First Support	31.2
Second Support	31.2
Third Support	31.2

Day RSI	43.3
Day MACD	-1.2
Day MFI	54.2
Day MACD Signal Line	-1.4

Goldline Pharmaceutical Beta

1 Month	-0.5
1 Year	-

3 Month	0.3
3 Year	-

Goldline Pharmaceutical Price Change Analysis

↓-1.6%

Over 1 Month

LowHigh

28.134.8

↓-24.4%

Over 3 Months

LowHigh

28.146.0

Over 6 Months

LowHigh

28.160

Over 1 Year

LowHigh

28.160

Goldline Pharmaceutical Shareholding Pattern/ Ownership

Shareholding Summary

Sep 2026

Name	Category	Shares	Shares %
Swapan Kumar Khandelwal	Promoter	2,887,988	30.1 %
Sumit Bilgaiyan	Public	678,000	7.1 %

HISTORICAL PROMOTER HOLDING

HISTORICAL FII HOLDING

HISTORICAL MF HOLDING

All Shareholding details

Goldline Pharmaceutical Deals - Insider, Bulk, Block and SAST

Client Name	Deal Type	Action	Date	Avg. Price	Quantity	Exchange
PRIYA KABRA	Bulk	Purchase	01 Sep 2026	40.91	51,000	BSE
PRIYA KABRA	Bulk	Sell	01 Sep 2026	40.71	51,000	BSE
VEER SINGH THAKUR	Bulk	Sell	31 Aug 2026	41	60,000	BSE
AMOL LAXMIKANT MUJUMDAR	Bulk	Purchase	31 Aug 2026	41	60,000	BSE
SWAPAN KHANDELWAL	Bulk	Purchase	28 Aug 2026	40.97	78,000	BSE
CUMULATIVE CAPITAL PRIVATE LIMITED	Bulk	Sell	25 Aug 2026	40.15	51,000	BSE
VEER SINGH THAKUR	Bulk	Sell	25 Aug 2026	40	3,000	BSE
VEER SINGH THAKUR	Bulk	Purchase	25 Aug 2026	40.15	51,000	BSE
AJIT SINGH	Bulk	Purchase	25 Aug 2026	40.04	60,000	BSE
KAILASH KABRA	Bulk	Sell	25 Aug 2026	40.10	96,000	BSE

All deals

All insider trades

Goldline Pharmaceutical Corporate Actions

Goldline Pharmaceutical Board Meetings

Goldline Pharmaceutical past and upcoming board meetings.

#Ex-Date	Purpose	Notes
109 Jun 2026	Audited Results	-

All Corporate Actions

Goldline Pharmaceutical Corporate Filings

Goldline Pharmaceutical BSE corporate filings and AGM, press releases, insider trading & SAST, results and corporate actions.

Date	Announcement Title	Details	Links
12 Oct 2026	Goldline Pharmaceutical Ltd - 544759 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018	Certificate under Regulation 74(5) for quarter and half year ended September 30, 2026.	PDF
24 Sep 2026	Goldline Pharmaceutical Ltd - 544759 - Closure of Trading Window	Intimation of Closure of Trading window	PDF
02 Sep 2026	Goldline Pharmaceutical Ltd - 544759 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011	The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Amol Mujumdar	PDF
02 Sep 2026	Goldline Pharmaceutical Ltd - 544759 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011	The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Amol Mujumdar	PDF
01 Sep 2026	Goldline Pharmaceutical Ltd - 544759 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011	The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Amol Laxmikant Mujumdar	PDF

VIEW ALL

Goldline Pharmaceutical DocumentsAsk MarketMind AI

Goldline Pharmaceutical Credit Ratings

Goldline Pharmaceutical credit ratings from CRISIL and leading rating agencies, assessing financial stability, investment grade, and related PDF documentation.

Date	Rating Agency	Company Name	Description	Links
22 Sep 2026	crisil ratings	Goldline Pharmaceutical Limited	Goldline Pharmaceutical Limited:Issuer not cooperating, based on best-available information; Rating revised to 'Crisil B/Stable Issuer not cooperating\u2019	Link

Goldline Pharmaceutical - Company Profile

Goldline Pharmaceutical Management Structure

Goldline Pharmaceutical management structure with salaries, total experience, and qualifications.

NAME	DESIGNATION	GROSS REMUNERATION ₹(LAC)	AS OF	HISTORY & DETAILS
Ms. Dipti Sharad Bhusari	Chief Financial Officer	4.9	Mar 26
Ruchi Sanket Modi	Company Secretary,Compliance Officer	2.63	Mar 26

About

Website: www.goldlinepharma.in

About the company - Business Profile

Goldline Pharmaceutical was incorporated on August 02, 2004. The company markets pharmaceutical products under the “Goldline” brand across five segments, including pharma, wellness, and ayurvedic categories. Its products are manufactured through third-party partners based on the company’s specifications, market research, and quality standards

Goldline Pharmaceutical FAQ

Goldline Pharmaceutical today is trading in the green, up by 0% at ₹31.2.

Goldline Pharmaceutical is currently trading up 0% on an intraday basis. In the past week the stock rose 3.65%. Stock has been down 24.38% in the past quarter You can view this in the share price history/seasonality section.

Goldline Pharmaceutical is listed on BSE with ticker 544759. It's currently trading on BSE at a share price of ₹31.2.

The market cap of Goldline Pharmaceutical is ₹29.95 Cr. as of Oct 30, 2026.

Goldline Pharmaceutical has never announced any dividend since the time of its listing on the BSE exchange.

Goldline Pharmaceutical has never issued stock splits or bonus shares since the time of its listing on the BSE exchange.

Goldline Pharmaceutical reported ₹31.2 Cr. in revenue, ₹4.12 Cr. in net profit, and ₹6.94 Cr. in EBITD as of Mar 31, 2026 for FY25-26.

There are no analyst predictions for stock price target for Goldline Pharmaceutical.

The PE ratio of Goldline Pharmaceutical is 7.28 as of Oct 30, 2026.

The PB ratio of Goldline Pharmaceutical is 2.26 as of Oct 30, 2026.

There are no analyst reports for Goldline Pharmaceutical.

You can set real-time stock alerts on price, volume, SMA, and several other parameters by scrolling to the top of this page and clicking the bell icon on the far right-hand side of the stock overview.

Key Metrics
DVM
Price Chart
Forecaster
Financials
Technicals
Shareholding
Deals
Documents
Corporate actions
Company Profile

Goldline Pharmaceutical Live Share Price Today, Share Analysis and Chart

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

Goldline Pharmaceutical Stock Price Analysis

Week Price Range

Month Price Range

Goldline Pharmaceutical - Annual

Goldline Pharmaceutical annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Annual Revenue Goldline Pharmaceutical Mar-2026 Annual Revenue is Rs 31 Cr which is growth of 11.2% YoY.

Annual Net Profit Goldline Pharmaceutical Mar-2026 Annual Net Profit is Rs 4 Cr which is growth of 45.4% YoY.

Goldline Pharmaceutical Technical Analysis

Goldline Pharmaceutical EMA & SMA

Goldline Pharmaceutical Delivery And Volume

Goldline Pharmaceutical Active Candlesticks

Goldline Pharmaceutical Resistance and Support

Goldline Pharmaceutical Beta

Goldline Pharmaceutical Price Change Analysis

Goldline Pharmaceutical Shareholding Pattern/ Ownership

Shareholding Summary

HISTORICAL PROMOTER HOLDING

HISTORICAL FII HOLDING

HISTORICAL MF HOLDING

Goldline Pharmaceutical Deals - Insider, Bulk, Block and SAST

Bulk Block Deals

Insider Trading & SAST

Goldline Pharmaceutical Corporate Actions

Goldline Pharmaceutical Board Meetings

Goldline Pharmaceutical past and upcoming board meetings.

Goldline Pharmaceutical Corporate Filings

Goldline Pharmaceutical BSE corporate filings and AGM, press releases, insider trading & SAST, results and corporate actions.

Goldline Pharmaceutical DocumentsAsk MarketMind AI

Goldline Pharmaceutical Credit Ratings

Goldline Pharmaceutical credit ratings from CRISIL and leading rating agencies, assessing financial stability, investment grade, and related PDF documentation.

Goldline Pharmaceutical - Company Profile

Goldline Pharmaceutical Management Structure

Goldline Pharmaceutical management structure with salaries, total experience, and qualifications.

About the company - Business Profile

Goldline Pharmaceutical FAQ

How is Goldline Pharmaceutical today?

Goldline Pharmaceutical today is trading in the green, up by 0% at ₹31.2.

How has Goldline Pharmaceutical performed historically?

Goldline Pharmaceutical is currently trading up 0% on an intraday basis. In the past week the stock rose 3.65%. Stock has been down 24.38% in the past quarter You can view this in the share price history/seasonality section.

What is the current share price of Goldline Pharmaceutical on NSE and BSE exchanges?

Goldline Pharmaceutical is listed on BSE with ticker 544759. It's currently trading on BSE at a share price of ₹31.2.

What is the market cap of Goldline Pharmaceutical?

The market cap of Goldline Pharmaceutical is ₹29.95 Cr. as of Oct 30, 2026.

When did Goldline Pharmaceutical last pay a dividend, and what has its dividend history been?

Goldline Pharmaceutical has never announced any dividend since the time of its listing on the BSE exchange.

Has Goldline Pharmaceutical issued any bonus shares or share splits recently?

Goldline Pharmaceutical has never issued stock splits or bonus shares since the time of its listing on the BSE exchange.

What do the financial statements and annual reports of Goldline Pharmaceutical Indicate?

Goldline Pharmaceutical reported ₹31.2 Cr. in revenue, ₹4.12 Cr. in net profit, and ₹6.94 Cr. in EBITD as of Mar 31, 2026 for FY25-26.

What is the target share price of Goldline Pharmaceutical according to analyst predictions in FY26-27?

There are no analyst predictions for stock price target for Goldline Pharmaceutical.

What is the PE Ratio of Goldline Pharmaceutical?

The PE ratio of Goldline Pharmaceutical is 7.28 as of Oct 30, 2026.

What is the PB Ratio of Goldline Pharmaceutical?

The PB ratio of Goldline Pharmaceutical is 2.26 as of Oct 30, 2026.

Where can I check the latest Research Reports about Goldline Pharmaceutical?

There are no analyst reports for Goldline Pharmaceutical.

How can I be notified of real time alerts about Goldline Pharmaceutical stock?

You can set real-time stock alerts on price, volume, SMA, and several other parameters by scrolling to the top of this page and clicking the bell icon on the far right-hand side of the stock overview.